HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yee Chao Selected Research

Fluorouracil (Carac)

1/2022Nanoliposomal irinotecan with 5-fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy: A real-world experience.
12/2021Affibody-conjugated 5-fluorouracil prodrug system preferentially targets and inhibits HER2-expressing cancer cells.
1/2016A Phase II Study of Sequential Capecitabine Plus Oxaliplatin Followed by Docetaxel Plus Capecitabine in Patients With Unresectable Gastric Adenocarcinoma: The TCOG 3211 Clinical Trial.
10/2015Secondary Primary Malignancy Risk in Patients With Cervical Cancer in Taiwan: A Nationwide Population-Based Study.
1/2014Phase II multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancer.
10/2013Randomized, multicenter, open-label study of oxaliplatin plus fluorouracil/leucovorin versus doxorubicin as palliative chemotherapy in patients with advanced hepatocellular carcinoma from Asia.
12/2009A phase II trial of biweekly oxaliplatin with simplified schedule of 48-h infusion of high-dose 5-fluorouracil and leucorvin for advanced biliary tract carcinoma.
1/2008Chemotherapy with etoposide, doxorubicin, cisplatin, 5-fluorouracil, and leucovorin for patients with advanced hepatocellular carcinoma.
8/2007Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: the V-325 Study Group.
8/2007Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V-325 Study Group.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yee Chao Research Topics

Disease

87Neoplasms (Cancer)
01/2024 - 05/2003
60Hepatocellular Carcinoma (Hepatoma)
06/2024 - 05/2003
30Stomach Neoplasms (Stomach Cancer)
10/2023 - 05/2002
18Adenocarcinoma
03/2023 - 08/2005
12Neoplasm Metastasis (Metastasis)
12/2023 - 05/2003
9Disease Progression
01/2023 - 05/2012
8Colorectal Neoplasms (Colorectal Cancer)
04/2024 - 03/2011
8Carcinoma (Carcinomatosis)
01/2022 - 09/2004
8Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 07/2002
7Fever (Fevers)
01/2016 - 03/2005
6Colonic Neoplasms (Colon Cancer)
01/2021 - 05/2007
6Neutropenia
01/2018 - 09/2003
5Gastric Outlet Obstruction
01/2022 - 12/2012
5Fibrosis (Cirrhosis)
01/2022 - 01/2016
5Carcinogenesis
05/2020 - 01/2013
4Hypertension (High Blood Pressure)
01/2024 - 10/2013
4Microsatellite Instability
01/2023 - 12/2019
4Fatigue
01/2016 - 03/2005
3Infections
04/2024 - 01/2019
3Rectal Neoplasms (Rectal Cancer)
06/2021 - 03/2005
3Liver Cirrhosis (Hepatic Cirrhosis)
01/2020 - 12/2003
3Vomiting
05/2018 - 09/2003
3Diarrhea
05/2018 - 03/2013
3Nausea
05/2018 - 09/2003
3Cholangiocarcinoma
03/2017 - 01/2013
3Inflammation (Inflammations)
01/2016 - 09/2005
3Leukemia
03/2012 - 01/2004
2Hepatitis
04/2024 - 04/2021
2Proteinuria
01/2024 - 01/2018
2Anemia
01/2024 - 09/2013
2Lymphatic Metastasis
10/2023 - 03/2017
2Prostatic Neoplasms (Prostate Cancer)
01/2023 - 03/2012
2Biliary Tract Neoplasms (Biliary Tract Cancer)
10/2022 - 01/2016
2Brain Stem Neoplasms (Brain Stem Tumor)
04/2022 - 02/2020
2Duodenal Obstruction
01/2022 - 01/2020
2Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2022 - 09/2004
2Brain Neoplasms (Brain Tumor)
04/2021 - 06/2020
2Hepatitis B
02/2021 - 08/2007

Drug/Important Bio-Agent (IBA)

22Sorafenib (BAY 43-9006)FDA Link
06/2024 - 03/2013
15Fluorouracil (Carac)FDA LinkGeneric
01/2022 - 07/2002
13Biomarkers (Surrogate Marker)IBA
01/2023 - 11/2019
13NivolumabIBA
10/2022 - 12/2017
12Cisplatin (Platino)FDA LinkGeneric
09/2022 - 07/2002
11GemcitabineFDA Link
10/2022 - 09/2003
9pembrolizumabIBA
09/2023 - 04/2017
9alpha-Fetoproteins (alpha-Fetoprotein)IBA
07/2023 - 12/2009
8Immune Checkpoint InhibitorsIBA
01/2024 - 11/2019
8Leucovorin (Folinic Acid)FDA Link
01/2022 - 07/2002
7BilirubinIBA
07/2023 - 01/2018
7AlbuminsIBA
07/2023 - 01/2018
7Proteins (Proteins, Gene)FDA Link
12/2021 - 07/2007
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 - 05/2003
6Docetaxel (Taxotere)FDA Link
01/2016 - 08/2005
6Doxorubicin (Adriamycin)FDA LinkGeneric
03/2015 - 01/2008
5Trastuzumab (Herceptin)FDA Link
12/2023 - 12/2014
5DNA (Deoxyribonucleic Acid)IBA
10/2023 - 12/2012
5Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2016 - 12/2009
4B7-H1 AntigenIBA
03/2023 - 06/2020
4LigandsIBA
03/2023 - 01/2004
4Antiviral Agents (Antivirals)IBA
10/2022 - 01/2017
4Hepatitis B Surface Antigens (HBsAg)FDA Link
09/2022 - 12/2018
4regorafenibIBA
04/2022 - 01/2020
4CytokinesIBA
08/2021 - 09/2005
4ErbB Receptors (EGF Receptor)IBA
01/2021 - 05/2012
3Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2024 - 12/2014
3AntigensIBA
02/2020 - 03/2017
3PlatinumIBA
01/2020 - 01/2016
3Phosphotransferases (Kinase)IBA
08/2019 - 03/2012
3Serum AlbuminIBA
12/2018 - 12/2014
3RamucirumabIBA
04/2018 - 03/2016
3Capecitabine (Xeloda)FDA Link
01/2017 - 04/2014
3Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
01/2016 - 10/2013
3TegafurIBA
06/2011 - 03/2005
3Etoposide (VP 16)FDA LinkGeneric
11/2009 - 07/2002
2Tumor Biomarkers (Tumor Markers)IBA
07/2023 - 07/2018
2Circulating Tumor DNAIBA
01/2023 - 01/2020
2margetuximabIBA
01/2023 - 01/2020
2Messenger RNA (mRNA)IBA
01/2023 - 06/2021
2lenvatinibIBA
10/2022 - 01/2022
2Tenofovir (Viread)FDA Link
09/2022 - 12/2018
2entecavirFDA Link
09/2022 - 12/2018
2Irinotecan (Camptosar)FDA LinkGeneric
01/2022 - 03/2011
2tislelizumabIBA
01/2022 - 01/2020
2ProdrugsIBA
12/2021 - 06/2011
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
10/2021 - 05/2013
2AntibodiesIBA
02/2021 - 12/2017
2CreatinineIBA
02/2021 - 12/2018
2Indicators and Reagents (Reagents)IBA
01/2021 - 12/2019

Therapy/Procedure

46Therapeutics
01/2024 - 07/2002
45Drug Therapy (Chemotherapy)
03/2023 - 07/2002
11Radiotherapy
04/2024 - 03/2005
8Immunotherapy
01/2024 - 03/2005
7Gastrectomy
01/2023 - 08/2011
5Stents
01/2022 - 12/2012
4Self Expandable Metallic Stents
01/2022 - 07/2015
4Chemoradiotherapy
01/2015 - 09/2003
3Boron Neutron Capture Therapy
04/2022 - 06/2020
2Microspheres (Microsphere)
04/2024 - 04/2021
2Salvage Therapy
01/2022 - 01/2020
2Aftercare (After-Treatment)
01/2022 - 01/2018